Premium
Calcium antagonists and multi‐infarct dementia: A trial involving sequential NMR and psychometric assessment
Author(s) -
Besson J. A. O.,
Palin A. N.,
Ebmeier K. P.,
Eagles J. M.,
Smith F. W.
Publication year - 1988
Publication title -
international journal of geriatric psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 129
eISSN - 1099-1166
pISSN - 0885-6230
DOI - 10.1002/gps.930030206
Subject(s) - dementia , nimodipine , placebo , antagonist , medicine , clinical trial , calcium , psychology , cardiology , physical therapy , pathology , disease , alternative medicine , receptor
Abstract A double‐blind placebo‐controlled trial of the calcium antagonist Nimodipine in 10 patients with multi‐infarct dementia (MID) shows that there is no improvement when compared with 10 patients on placebo assessed by clinical ratings and sequential NMR imaging. The value of repeated NMR imaging in measuring changes in MID is described.